BiotechTube
Home/ReGenX Biosciences/Timothy Miller
TM

Timothy Miller

Strategic Advisor, Former President & CEO

ReGenX Biosciences

Therapeutic Areas

OphthalmologyRare Neurological DiseasesMetabolic Disorders

ReGenX Biosciences Pipeline

DrugIndicationPhase
RGX-314Wet Age-Related Macular Degeneration (wAMD)Phase II
RGX-121Mucopolysaccharidosis Type II (MPS II)Phase I/II
RGX-181CLN2 Disease (Batten Disease)Phase I/II
RGX-111Mucopolysaccharidosis Type I (MPS I)Phase I/II
RGX-381Ocular manifestations of Epidermolysis BullosaPhase I/II

Leadership Team at ReGenX Biosciences

KT
Kenneth T. Mills
President and Chief Executive Officer
CS
Curran Simpson
Chief Operating Officer
SP
Steve Pakola
Chief Medical Officer
OD
Olivier Danos
Chief Scientific Officer
VV
Vittal Vasista
Chief Financial Officer
View full ReGenX Biosciences profile